Jie Ran - Search Results

Year	Number of Results
2011	1
2014	6
2015	3
2016	3
2017	3
2018	3
2019	5
2020	8
2021	11
2022	5
2023	4
2024	7

1

Non-canonical functions of the mitotic kinesin Eg5.

Liu M, Ran J, Zhou J. Liu M, et al. Among authors: ran j. Thorac Cancer. 2018 Aug;9(8):904-910. doi: 10.1111/1759-7714.12792. Epub 2018 Jun 21. Thorac Cancer. 2018. PMID: 29927078 Free PMC article. Review.

2

Inducible Degradation of Oncogenic Nucleolin Using an Aptamer-Based PROTAC.

Chen M, Zhou P, Kong Y, Li J, Li Y, Zhang Y, Ran J, Zhou J, Chen Y, Xie S. Chen M, et al. Among authors: ran j. J Med Chem. 2023 Jan 26;66(2):1339-1348. doi: 10.1021/acs.jmedchem.2c01557. Epub 2023 Jan 6. J Med Chem. 2023. PMID: 36608275

3

Lite It Fly: An All-Deformable-Butterfly Network.

Lin R, Li JCL, Zhou J, Huang B, Ran J, Wong N. Lin R, et al. Among authors: ran j. IEEE Trans Neural Netw Learn Syst. 2023 Nov 28;PP. doi: 10.1109/TNNLS.2023.3333562. Online ahead of print. IEEE Trans Neural Netw Learn Syst. 2023. PMID: 38015682

4

Targeted inhibition of histone deacetylase 6 in inflammatory diseases.

Ran J, Zhou J. Ran J, et al. Thorac Cancer. 2019 Mar;10(3):405-412. doi: 10.1111/1759-7714.12974. Epub 2019 Jan 21. Thorac Cancer. 2019. PMID: 30666796 Free PMC article. Review.

5

Accuracy of cytokeratin 19 fragment in the diagnosis of bladder cancer.

Zhu RJ, Zhou J, Liang PQ, Xiang XX, Ran J, Xie TA, Guo XG. Zhu RJ, et al. Among authors: ran j. Biomark Med. 2022 Feb;16(3):197-216. doi: 10.2217/bmm-2021-0754. Epub 2022 Feb 3. Biomark Med. 2022. PMID: 35112920 Review.

6

Postmarketing Safety of Sacituzumab Govitecan: A Pharmacovigilance Study Based on the FDA Adverse Event Reporting System.

Li X, Zhang L, Hu S, Liu D, Hu B, Ran J, Lin X, Mao W, Hu J. Li X, et al. Among authors: ran j. Clin Pharmacol Ther. 2024 Feb;115(2):256-268. doi: 10.1002/cpt.3098. Epub 2023 Dec 14. Clin Pharmacol Ther. 2024. PMID: 37994531

7

Targeting the photoreceptor cilium for the treatment of retinal diseases.

Ran J, Zhou J. Ran J, et al. Acta Pharmacol Sin. 2020 Nov;41(11):1410-1415. doi: 10.1038/s41401-020-0486-3. Epub 2020 Aug 4. Acta Pharmacol Sin. 2020. PMID: 32753732 Free PMC article. Review.

8

Ciliopathies: Does HDAC6 Represent a New Therapeutic Target?

Yu F, Ran J, Zhou J. Yu F, et al. Among authors: ran j. Trends Pharmacol Sci. 2016 Feb;37(2):114-119. doi: 10.1016/j.tips.2015.11.002. Epub 2015 Dec 2. Trends Pharmacol Sci. 2016. PMID: 26651415 Review.

9

Targeting the HDAC6-Cilium Axis Ameliorates the Pathological Changes Associated with Retinopathy of Prematurity.

Ran J, Zhang Y, Zhang S, Li H, Zhang L, Li Q, Qin J, Li D, Sun L, Xie S, Zhang X, Liu L, Liu M, Zhou J. Ran J, et al. Adv Sci (Weinh). 2022 Jul;9(21):e2105365. doi: 10.1002/advs.202105365. Epub 2022 May 26. Adv Sci (Weinh). 2022. PMID: 35619548 Free PMC article.

10

Regulation of ciliary homeostasis by intraflagellar transport-independent kinesins.

Li L, Ran J. Li L, et al. Among authors: ran j. Cell Death Dis. 2024 Jan 13;15(1):47. doi: 10.1038/s41419-024-06428-9. Cell Death Dis. 2024. PMID: 38218748 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

51 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year